These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 32028423
1. Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study. Liu W, Zhou X, Li Y, Zhang S, Cai X, Zhang R, Gong S, Han X, Ji L. Medicine (Baltimore); 2020 Feb; 99(6):e19052. PubMed ID: 32028423 [Abstract] [Full Text] [Related]
2. Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs. Farooq R, Amin S, Hayat Bhat M, Malik R, Wani HA, Majid S. Gynecol Endocrinol; 2017 Jan; 33(1):75-78. PubMed ID: 27705028 [Abstract] [Full Text] [Related]
3. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Hansen D, Dendale P, Beelen M, Jonkers RA, Mullens A, Corluy L, Meeusen R, van Loon LJ. Eur J Appl Physiol; 2010 Jun; 109(3):397-404. PubMed ID: 20131064 [Abstract] [Full Text] [Related]
4. Relationships among resistin, adiponectin, and leptin and microvascular complications in patients with type 2 diabetes mellitus. Wang LK, Wang H, Wu XL, Shi L, Yang RM, Wang YC. J Int Med Res; 2020 Apr; 48(4):300060519870407. PubMed ID: 31891278 [Abstract] [Full Text] [Related]
11. Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study. Mir MM, Mir R, Alghamdi MAA, Wani JI, Sabah ZU, Jeelani M, Marakala V, Sohail SK, O'haj M, Alharthi MH, Alamri MMS. J Pers Med; 2022 May 01; 12(5):. PubMed ID: 35629157 [Abstract] [Full Text] [Related]
15. Correlations between serum adipocytokine concentrations, disease stage, radiological status and total body fat content in the patients with primary knee osteoarthritis. Richter M, Trzeciak T, Rybka JD, Suchorska W, Augustyniak E, Lach M, Kaczmarek M, Kaczmarczyk J. Int Orthop; 2017 May 01; 41(5):983-989. PubMed ID: 28013331 [Abstract] [Full Text] [Related]
17. Adipokine Profile in Patients with Type 2 Diabetes Depends on Degree of Obesity. Kocot J, Dziemidok P, Kiełczykowska M, Hordyjewska A, Szcześniak G, Musik I. Med Sci Monit; 2017 Oct 19; 23():4995-5004. PubMed ID: 29049270 [Abstract] [Full Text] [Related]
18. Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention. Rajkovic N, Zamaklar M, Lalic K, Jotic A, Lukic L, Milicic T, Singh S, Stosic L, Lalic NM. Int J Environ Res Public Health; 2014 Apr 14; 11(4):4049-65. PubMed ID: 24736687 [Abstract] [Full Text] [Related]
19. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Eur J Endocrinol; 2003 Oct 14; 149(4):331-5. PubMed ID: 14514348 [Abstract] [Full Text] [Related]
20. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA. Clin Endocrinol (Oxf); 2009 Feb 14; 70(2):221-6. PubMed ID: 18505467 [Abstract] [Full Text] [Related] Page: [Next] [New Search]